MAB3315
MMP-7抗体，克隆141-7B2
clone 141-7B2, Chemicon®, from mouse
别名:
Matrilysin
登录 查看组织和合同定价。
选择尺寸
关于此项目
UNSPSC Code:
12352203
NACRES:
NA.41
eCl@ss:
32160702
Conjugate:
unconjugated
Clone:
141-7B2, monoclonal
Application:
ELISA
immunohistochemistry
western blot
immunohistochemistry
western blot
Species reactivity:
human
Citations:
16
Technique(s):
ELISA: suitable
immunohistochemistry: suitable (paraffin)
western blot: suitable
immunohistochemistry: suitable (paraffin)
western blot: suitable
Uniprot accession no.:
产品名称
MMP-7抗体，克隆141-7B2, clone 141-7B2, Chemicon®, from mouse
biological source
mouse
conjugate
unconjugated
antibody form
purified immunoglobulin
clone
141-7B2, monoclonal
species reactivity
human
manufacturer/tradename
Chemicon®
technique(s)
ELISA: suitable
immunohistochemistry: suitable (paraffin)
western blot: suitable
isotype
IgG1κ
NCBI accession no.
UniProt accession no.
shipped in
dry ice
target post-translational modification
unmodified
Quality Level
相关类别
Application
MMP-7抗体（克隆141-7B2）是一种针对MMP-7的抗体，可用于ELISA、WB、IH(P)。
免疫印迹：10 μg/mL，分子量条带约30kDa。
在石蜡包埋的组织切片上进行的免疫组化分析：4-20 μg/mL
EIA
最佳工作稀释度必须由最终用户确定。
在石蜡包埋的组织切片上进行的免疫组化分析：4-20 μg/mL
EIA
最佳工作稀释度必须由最终用户确定。
研究子类别
MMPs & TIMPs
MMPs & TIMPs
研究类别
细胞结构
细胞结构
Biochem/physiol Actions
该抗体与人MMP-7的前体形式特异性反应。 不与人MMP-7的活性形式以及人MMP-1、2、3、8、9和13交叉反应。
Disclaimer
由Daiichi Fine Chemical Co., Ltd生产
除非我们的产品目录或产品附带的其他公司文档另有说明，否则我们的产品仅供研究使用，不得用于任何其他目的，包括但不限于未经授权的商业用途、体外诊断用途、离体或体内治疗用途或任何类型的消费或应用于人类或动物。
除非我们的产品目录或产品附带的其他公司文档另有说明，否则我们的产品仅供研究使用，不得用于任何其他目的，包括但不限于未经授权的商业用途、体外诊断用途、离体或体内治疗用途或任何类型的消费或应用于人类或动物。
Immunogen
直肠癌（SW837）细胞。
Other Notes
浓度：请参考批次特异性浓缩物的检验报告。
Physical form
形式：纯化
纯化的免疫球蛋白。 液体，溶于含有2%无蛋白酶的牛血清白蛋白的0.1 M磷酸钠缓冲液（pH 7.0）中。
Preparation Note
收到货后，在-20°C下以未稀释等分试样可保存长达12个月。 应避免反复冻/融循环。
Legal Information
CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany
存储类别
12 - Non Combustible Liquids
wgk
WGK 2
flash_point_f
Not applicable
flash_point_c
Not applicable
Prognostic value of E-cadherin, beta-catenin, MMPs (7 and 9), and TIMPs (1 and 2) in patients with colorectal carcinoma.
Fernanda Roca, Laura V Mauro, Ana Morandi, Fernando Bonadeo, Carlos Vaccaro et al.
Journal of Surgical Oncology null
Yali Zhai et al.
The American journal of pathology, 160(4), 1229-1238 (2002-04-12)
In various cancers, inactivating mutations in the adenomatous polyposis coli or Axin tumor suppressor proteins or activating mutations in beta-catenin's amino-terminal domain elevate beta-catenin levels, resulting in marked effects on T-cell factor (TCF)-regulated transcription. Several candidate beta-catenin/TCF-regulated genes in cancer
DSG3 facilitates cancer cell growth and invasion through the DSG3-plakoglobin-TCF/LEF-Myc/cyclin D1/MMP signaling pathway.
Chen, YJ; Lee, LY; Chao, YK; Chang, JT; Lu, YC; Li, HF; Chiu, CC; Li, YC; Li, YL; Chiou et al.
Testing null
Jiang Fan et al.
Oncology letters, 2(6), 1269-1273 (2012-08-01)
The molecular profile of low-grade mucoepidermoid carcinomas remains to be clarified. In the present study, matrix metalloproteinase (MMP) expression was compared in low-grade mucoepidermoid carcinoma (MEC) and typical lung cancer. The expression of MMP-2, MMP-7 and MMP-9 was detected by
Anna Kerola et al.
The journal of pathology. Clinical research, 2(3), 187-198 (2016-08-09)
The molecular mechanisms underlying progressive liver fibrosis following surgical treatment of biliary atresia (BA) remain unclear. Our aim was to address hepatic gene and protein expression and serum levels of matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) after successful
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持